Acute Kidney Injury and Chronic Kidney Disease After Cardiac Surgery

Advances in Chronic Kidney Disease

Volumn 15, Issue 3, 2008, Pages 257-277

  Stafford Smith, Mark ^a   Patel, Uptal D ^a   Phillips Bute, Barbara G ^a   Shaw, Andrew D ^a   Swaminathan, Madhav ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Cardiac surgery; Postoperative complications

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY DISEASE; HEART ARREST; HEART SURGERY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY;

CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, ACUTE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 45249090103     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.04.006     Document Type: Article

References (209)

1. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14 (1999) 1158-1162
2. Chertow G.M., Levy E.M., Hammermeister K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104 (1998) 343-348
3. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16 (2005) 195-200
4. Cooper W.A., O'Brien S.M., Thourani V.H., et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
5. Zacharias M., Gilmore I., Herbison G., et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev (2005) CD003590
6. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
7. Swaminathan M., Shaw A.D., Phillips-Bute B.G., et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med 35 (2007) 2286-2291
8. Stafford-Smith M., Phillips-Bute B., Reddan D.N., et al. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. Anesth Analg 91 (2000) 1085-1090
9. Stafford-Smith M. Heart and kidneys: Sharing more than just blood. Curr Opin Anaesthesiol 20 (2007) 65-69
10. Bhandari S., and Turney J.H. Survivors of acute renal failure who do not recover renal function. Q J Med 89 (1996) 415-421
11. Stafford-Smith M. Perioperative renal dysfunction: Implications and strategies for protection. In: Newman M.F. (Ed). Perioperative Organ Protection (2003), Lippincott Williams & Wilkins, Baltimore, MD 89-124
12. Brown R., Babcock R., Talbert J., et al. Renal function in critically ill postoperative patients: Sequential assessment of creatinine osmolar and free water clearance. Crit Care Med 8 (1980) 68-72
13. Holper K., Struck E., and Sebening F. The diagnosis of acute renal failure (ARF) following cardiac surgery with cardio-pulmonary bypass. Thorac Cardiovasc Surg 27 (1979) 231-237
14. McCreath B.J., Swaminathan M., Booth J.V., et al. Mitral valve surgery and acute renal injury: Port access versus median sternotomy. Ann Thorac Surg 75 (2003) 812-819
15. Gamoso M.G., Phillips-Bute B., Landolfo K.P., et al. Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg 91 (2000) 1080-1084
16. Fischer S.S., Phillips-Bute B., Swaminathan M., et al. Symmetry aortic connector devices and acute renal injury: A comparison of renal dysfunction after three different aortocoronary bypass surgery techniques. Anesth Analg 102 (2006) 25-31
17. Morozowich S., Lin S., Phillips-Bute B., et al. Aprotinin use and allograft function after off-pump bilateral lung transplantation. Anesth Analg 102 (2006) SCA6
18. Hix J.K., Thakar C.V., Katz E.M., et al. Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med 34 (2006) 2979-2983
19. Mora-Mangano C., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128 (1998) 194-203
20. Mehta R.H., Grab J.D., O'Brien S.M., et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 114 (2006) 2208-2216
21. Appoo J.J., Augoustides J.G., Pochettino A., et al. Perioperative outcome in adults undergoing elective deep hypothermic circulatory arrest with retrograde cerebral perfusion in proximal aortic arch repair: Evaluation of protocol-based care. J Cardiothorac Vasc Anesth 20 (2006) 3-7
22. Boyle J.M., Moualla S., Arrigain S., et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis 48 (2006) 787-796
23. Rocha P.N., Rocha A.T., Palmer S.M., et al. Acute renal failure after lung transplantation: Incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 5 (2005) 1469-1476
24. Safi H.J., Harlin S.A., Miller C.C., et al. Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery. J Vasc Surg 24 (1996) 38-344
25. Topkara V.K., Dang N.C., Barili F., et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 25 (2006) 404-408
26. Chertow G.M., Lazarus J.M., Christiansen C.L., et al. Preoperative renal risk stratification. Circulation 95 (1997) 878-884
27. Praught M.L., and Shlipak M.G. Are small changes in serum creatinine an important risk factor?. Curr Opin Nephrol Hypertens 14 (2005) 265-270
28. Page U.S., and Washburn T. Using tracking data to find complications that physicians miss: The case of renal failure in cardiac surgery. Jt Comm J Qual Improv 23 (1997) 511-520
29. Hamel M.B., Phillips R.S., Davis R.B., et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 127 (1997) 195-202
30. Ferguson Jr. T.B., Dziuban Jr. S.W., Edwards F.H., et al. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg 69 (2000) 680-691
31. Barrett B.J., and Parfrey P.S. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331 (1994) 1449-1450
32. American Society of Nephrology Renal Research Report. J Am Soc Nephrol 16 (2005) 1886-1903
33. Eknoyan G., Lameire N., Barsoum R., et al. The burden of kidney disease: Improving global outcomes. Kidney Int 66 (2004) 1310-1314
34. Thompson B.T., Cox P.N., Antonelli M., et al. Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: Executive summary. Crit Care Med 32 (2004) 1781-1784
35. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105 (2006) 485-491
36. Stafford-Smith M. Antifibrinolytic agents make alpha1- and beta2-microglobulinuria poor markers of post cardiac surgery renal dysfunction. Anesthesiology 90 (1999) 928-929
37. Feindt P.R., Walcher S., Volkmer I., et al. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. Ann Thorac Surg 60 (1995) 1076-1080
38. Parikh C.R., Jani A., Melnikov V.Y., et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43 (2004) 405-414
39. Parikh C.R., Mishra J., Thiessen-Philbrook H., et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70 (2006) 199-203
40. Garwood S., Davis E., and Harris S.N. Intraoperative transesophageal ultrasonography can measure renal blood flow. J Cardiothorac Vasc Anesth 15 (2001) 65-71
41. Laissy J.P., Idee J.M., Fernandez P., et al. Magnetic resonance imaging in acute and chronic kidney diseases: present status. Nephron Clin Pract 103 (2006) c50-c57
42. Alpert R.A., Roizen M.F., Hamilton W.K., et al. Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 95 (1984) 707-711
43. Kainuma M., Yamada M., and Miyake T. Continuous urine oxygen tension monitoring in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 10 (1996) 603-608
44. Stafford-Smith M., and Grocott H.P. Renal medullary hypoxia during experimental cardiopulmonary bypass: A pilot study. Perfusion 20 (2005) 53-58
45. Andersson L.G., Bratteby L.E., Ekroth R., et al. Renal function during cardiopulmonary bypass: Influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 8 (1994) 597-602
46. Szabo G., Posch E., Rosivall L., et al. The effect of haemorrhage on renal blood flow and intrarenal flow distribution. Injury 9 (1977) 146-150
47. Loutzenhiser R., Griffin K., Williamson G., et al. Renal autoregulation: New perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1153-R1167
48. Arendshorst W.J., Brannstrom K., and Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 10 suppl 11 (1999) S149-S161
49. Brezis M., and Rosen S. Hypoxia of the renal medulla-Its implications for disease. N Engl J Med 332 (1995) 647-655
50. Geraghty J.G., Nsubuga M., Angerson W.J., et al. A study of regional distribution of renal blood flow using quantitative autoradiography. Am J Physiol 263 (1992) F958-F962
51. O'Connor P.M. Renal oxygen delivery: Matching delivery to metabolic demand. Clin Exp Pharmacol Physiol 33 (2006) 961-967
52. Cochrane J., Williams B.T., Banerjee A., et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail 21 (1999) 135-145
53. Lee H.T., and Emala C.W. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 278 (2000) F380-F387
54. Lee H.T., Gallos G., Nasr S.H., et al. A(1) adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 15 (2004) 102-111
55. Lieberthal W., and Levine J.S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271 (1996) F477-F488
56. Kribben A., Edelstein C.L., and Schrier R.W. Pathophysiology of acute renal failure. J Nephrol 12 suppl 2 (1999) S142-S151
57. Remuzzi G., and Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339 (1998) 1448-1456
58. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004) R204-R212
59. Hall R., Stafford-Smith M., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85 (1997) 766-782
60. Donnahoo K.K., Meldrum D.R., Shenkar R., et al. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 163 (2000) 1328-1332
61. Vanholder R., Argiles A., Baurmeister U., et al. Uremic toxicity: present state of the art. Int J Artif Organs 24 (2001) 695-725
62. Sreeram G.M., Grocott H.P., White W.D., et al. Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 18 (2004) 548-551
63. Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107 (1994) 1489-1495
64. Sinsteden T.D., O'Neil T.J., Hill S., et al. The role of high-energy phosphate in norepinephrine-induced acute renal failure in the dog. Circ Res 59 (1986) 93-104
65. Ozden A., Sarioglu A., Demirkan N.C., et al. Antithrombin III reduces renal ischemia-reperfusion injury in rats. Res Exp Med (Berl) 200 (2001) 195-203
66. Thornberry N.A. Caspases: key mediators of apoptosis. Chem Biol 5 (1998) R97-R103
67. Padanilam B.J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284 (2003) F608-F627
68. Ashkenazi A., and Dixit V.M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11 (1999) 255-260
69. Daemen M.A., de Vries B., and Buurman W.A. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73 (2002) 1693-1700
70. Daemen M.A., van't Veer C., Denecker G., et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104 (1999) 541-549
71. Cao C.C., Ding X.Q., Ou Z.L., et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65 (2004) 834-845
72. Lieberthal W., and Nigam S.K. Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 278 (2000) F1-F12
73. Barbut D., Hinton R.B., Szatrowski T.P., et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke 25 (1994) 2398-2402
74. Davila-Roman V.G., Kouchoukos N.T., Schechtman K.B., et al. Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117 (1999) 111-116
75. Reichenspurner H., Navia J.A., Berry G., et al. Particulate emboli capture by an intra-aortic filter device during cardiac surgery. J Thorac Cardiovasc Surg 119 (2000) 233-241
76. Nakamoto S., Kaneda T., Inoue T., et al. Disseminated cholesterol embolism after coronary artery bypass grafting. J Card Surg 16 (2001) 410-413
77. Blauth C.I., Cosgrove D.M., Webb B.W., et al. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 103 (1992) 1104-1111
78. Tierney G., Parissis H., Baker M., et al. An experimental study of intra aortic balloon pumping within the intact human aorta. Eur J Cardiothorac Surg 12 (1997) 486-493
79. Hosaka S., Suzuki S., Kato J., et al. [Modification of the surgical strategy based on intraoperative echographic findings of atherosclerotic ascending aorta]. Nippon Kyobu Geka Gakkai Zasshi 45 (1997) 1916-1921
80. Muehrcke D.D., Cornhill J.F., Thomas J.D., et al. Flow characteristics of aortic cannulae. J Card Surg 10 (1995) 514-519
81. Dietl C.A., Madigan N.P., Laubach C.A., et al. Myocardial revascularization using the "no-touch" technique, with mild systemic hypothermia, in patients with a calcified ascending aorta. J Cardiovasc Surg (Torino) 36 (1995) 39-44
82. St Amand M., Murkin J., Menkis A., et al. Aortic atherosclerotic plaque identified by epiaortic scanning predicts cerebral embolic load in cardiac surgery. Can J Anaesth 44 suppl (1997) A7
83. Banbury M.K., Kouchoukos N.T., Allen K.B., et al. Emboli capture using the Embol-X intraaortic filter in cardiac surgery: A multicentered randomized trial of 1,289 patients. Ann Thorac Surg 76 (2003) 508-515
84. Conlon P.J., Jefferies F., Krigman H.R., et al. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 49 (1998) 96-101
85. Shammas N.W. Pulmonary embolus after coronary artery bypass surgery: A review of the literature. Clin Cardiol 23 (2000) 637-644
86. Shann K.G., Likosky D.S., Murkin J.M., et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 132 (2006) 283-290
87. Deal D.D., Jones T.J., Vernon J.C., et al. Real time OPS imaging of embolic injury of the renal micro-circulation during cardiopulmonary bypass. Anesth Analg 92 (2001) S23
88. Murray K.D., Binkley P.F., Dumond D.A., et al. The significance and prevention of air emboli with the total artificial heart. Artif Organs 17 (1993) 734-740
89. Kalpokas M.V., Nixon I.K., Kluger R., et al. Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial. Perfusion 18 (2003) 291-294
90. Haase M., Haase-Fielitz A., Bagshaw S.M., et al. Cardiopulmonary bypass-associated acute kidney injury: A pigment nephropathy?. Contrib Nephrol 156 (2007) 340-353
91. Maccario M., Fumagalli C., Dottori V., et al. The association between rhabdomyolysis and acute renal failure in patients undergoing cardiopulmonary bypass. J Cardiovasc Surg (Torino) 37 (1996) 153-159
92. Schouten O., Bax J.J., Dunkelgrun M., et al. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg 44 (2006) 419-424
93. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
94. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
95. Tenstad O., Williamson H.E., Clausen G., et al. Glomerular filtration and tubular absorption of the basic polypeptide aprotinin. Acta Physiol Scand 152 (1994) 33-50
96. Thelle K., Christensen E.I., Vorum H., et al. Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats. Kidney Int 69 (2006) 1333-1340
97. Ferraris V.A., Bridges C.R., and Anderson R.P. Aprotinin in cardiac surgery. N Engl J Med 354 (2006) 1953-1957
98. Mangano D.T., Miao Y., Vuylsteke A., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
99. Provenchere S., Plantefeve G., Hufnagel G., et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 96 (2003) 1258-1264
100. Tune B. Renal tubular transport and nephrotoxicity of beta lactam antibiotics: Structure activity relationships. Miner Electrolyte Metab 20 (1994) 221-231
101. Bennett W.M., Luft F., and Porter G.A. Pathogenesis of renal failure due to aminoglycosides and contrast media used in roentgenography. Am J Med 69 (1980) 767-774
102. Baisac J., and Henrich W. Nephrotoxicity of nonsteroidal anti-inflammatory drugs. Miner Electrolyte Metab 20 (1994) 187-192
103. Olyaei A.J., de Mattos A.M., and Bennett W.M. Immunosuppressant-induced nephropathy: Pathophysiology, incidence and management. Drug Saf 21 (1999) 471-488
104. Baehler R.W., Williams R.H., Work J., et al. Studies on the natural history of the norepinephrine model of acute renal failure in the dog. Nephron 26 (1980) 266-273
105. Santos F.O., Silveira M.A., Maia R.B., et al. Acute renal failure after coronary artery bypass surgery with extracorporeal circulation-Incidence, risk factors, and mortality. Arq Bras Cardiol 83 (2004) 150-154
106. Spurgeon-Pechman K.R., Donohoe D.L., Mattson D.L., et al. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol 293 (2007) F269-F278
107. Basile D.P. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 72 (2007) 151-156
108. Eddy A.A., and Neilson E.G. Chronic kidney disease progression. J Am Soc Nephrol 17 (2006) 2964-2966
109. Hsu C.Y. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 16 (2007) 221-226
110. Levine S., and Saltzman A. Are urea and creatinine uremic toxins in the rat?. Ren Fail 23 (2001) 53-59
111. Tarnow L., Hovind P., Teerlink T., et al. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 27 (2004) 765-769
112. Kielstein J.T., Donnerstag F., Gasper S., et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37 (2006) 2024-2029
113. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
114. Aronson S., Fontes M.L., Miao Y., et al. Risk index for perioperative renal dysfunction/failure: Critical dependence on pulse pressure hypertension. Circulation 115 (2007) 733-742
115. Sulzer C., de Lange F., Yates R., et al. Renal dysfunction after deep hypothermic circulatory arrest in the rat. Anesth Analg 102 (2006) SCA41
116. Thakar C.V., Arrigain S., Worley S., et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16 (2005) 162-168
117. Tuttle K.R., Worrall N.K., Dahlstrom L.R., et al. Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 41 (2003) 76-83
118. Ouattara A., Lecomte P., Le Manach Y., et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103 (2005) 687-694
119. Llopart T., Lombardi R., Forselledo M., et al. Acute renal failure in open heart surgery. Ren Fail 19 (1997) 319-323
120. Andersson L.G., Ekroth R., Bratteby L.E., et al. Acute renal failure after coronary surgery-A study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 41 (1993) 237-241
121. Mangos G.J., Brown M.A., Chan W.Y., et al. Acute renal failure following cardiac surgery: Incidence, outcomes and risk factors. Aust N Z J Med 25 (1995) 284-289
122. Anderson R.J., O'Brien M., MaWhinney S., et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int 55 (1999) 1057-1062
123. Anderson R.J., O'Brien M., MaWhinney S., et al. Mild renal failure is associated with adverse outcome after cardiac valve surgery. Am J Kidney Dis 35 (2000) 1127-1134
124. Rao V., Weisel R.D., Buth K.J., et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation 96 (1997) II-38-II-43
125. DeFoe G.R., Ross C.S., Olmstead E.M., et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 71 (2001) 769-776
126. Yates R.B., and Stafford-Smith M. The genetic determinants of renal impairment following cardiac surgery. Semin Cardiothorac Vasc Anesth 10 (2006) 314-326
127. Stafford-Smith M., Podgoreanu M., Swaminathan M., et al. Association of genetic polymorphisms with risk of renal injury after coronary aftery bypass graft surgery. Am J Kidney Dis 45 (2005) 519-530
128. Chew S.T., Newman M.F., White W.D., et al. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93 (2000) 325-331
129. Charlson M., Krieger K.H., Peterson J.C., et al. Predictors and outcomes of cardiac complications following elective coronary bypass grafting. Proc Assoc Am Physicians 111 (1999) 622-632
130. Kincaid E.H., Ashburn D.A., Hoyle J.R., et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?. Ann Thorac Surg 80 (2005) 1388-1393
131. Textor S.C. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol 17 (1997) 67-76
132. Licker M., Schweizer A., Hohn L., et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. Can J Anaesth 46 (1999) 626-634
133. Conlon P.J., Crowley J., Stack R., et al. Renal artery stenosis is not associated with the development of acute renal failure following coronary artery bypass grafting. Ren Fail 27 (2005) 81-86
134. Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
135. Marathias K.P., Vassili M., Robola A., et al. Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artif Organs 30 (2006) 615-621
136. Davidson I.J. Renal impact of fluid management with colloids: A comparative review. Eur J Anaesthesiol 23 (2006) 721-738
137. Scott N.B., Turfrey D.J., Ray D.A., et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 93 (2001) 528-535
138. Lee H.T., Ota-Setlik A., Fu Y., et al. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101 (2004) 1313-1324
139. Cheng D.C., Bainbridge D., Martin J.E., et al. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102 (2005) 188-203
140. Sellke F.W., DiMaio J.M., Caplan L.R., et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 111 (2005) 2858-2864
141. Reston J.T., Tregear S.J., and Turkelson C.M. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 1510-1515
142. Tang A.T., Alexiou C., Hsu J., et al. Leukodepletion reduces renal injury in coronary revascularization: A prospective randomized study. Ann Thorac Surg 74 (2002) 372-377
143. Calafiore A.M., Bar-El Y., Vitolla G., et al. Early clinical experience with a new sutureless anastomotic device for proximal anastomosis of the saphenous vein to the aorta. J Thorac Cardiovasc Surg 121 (2001) 854-858
144. Wald R., Waikar S.S., Liangos O., et al. Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg 43 (2006) 460-466
145. Prinssen M., Verhoeven E.L., Buth J., et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351 (2004) 1607-1618
146. Lederle F.A., Kane R.L., MacDonald R., et al. Systematic review: Repair of unruptured abdominal aortic aneurysm. Ann Intern Med 146 (2007) 735-741
147. Doss M., Balzer J., Martens S., et al. Surgical versus endovascular treatment of acute thoracic aortic rupture: A single-center experience. Ann Thorac Surg 76 (2003) 1465-1469
148. Stafford-Smith M., and Newman M.F. What effects do hemodilution and blood transfusion during cardiopulmonary bypass have on renal outcomes?. Nat Clin Pract Nephrol 2 (2006) 188-189
149. Swaminathan M., East C., Phillips-Bute B., et al. Report of a substudy on warm versus cold cardiopulmonary bypass: Changes in creatinine clearance. Ann Thorac Surg 72 (2001) 1603-1609
150. Swaminathan M., Phillips-Bute B.G., Conlon P.J., et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary bypass surgery. Ann Thorac Surg 76 (2003) 784-791
151. Urzua J., Troncoso S., Bugedo G., et al. Renal function and cardiopulmonary bypass: Effect of perfusion pressure. J Cardiothorac Vasc Anesth 6 (1992) 299-303
152. Valentine S., Barrowcliffe M., and Peacock J. A comparison of effects of fixed and tailored cardiopulmonary bypass flowrates on renal function. [see comments]. Anaesth Intensive Care 21 (1993) 304-308
153. Holmes C.L., Walley K.R., Chittock D.R., et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 27 (2001) 1416-1421
154. Friedrich J.O., Adhikari N., Herridge M.S., et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142 (2005) 510-524
155. Holmes C.L., and Walley K.R. Bad medicine: Low-dose dopamine in the ICU. Chest 123 (2003) 1266-1275
156. Argalious M., Motta P., Khandwala F., et al. Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med 33 (2005) 1327-1332
157. Jones D., and Bellomo R. Renal-dose dopamine: From hypothesis to paradigm to dogma to myth and, finally, superstition?. J Intensive Care Med 20 (2005) 199-211
158. Prins I., Plotz F.B., Uiterwaal C.S., et al. Low-dose dopamine in neonatal and pediatric intensive care: A systematic review. Intensive Care Med 27 (2001) 206-210
159. McHugh G.J. Current usage of dopamine in New Zealand intensive care units. Anaesth Intensive Care 29 (2001) 623-626
160. Bove T., Landoni G., Grazia Calabro M., et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 111 (2005) 3230-3235
161. Caimmi P.P., Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 491-494
162. Tumlin J.A., Finkel K.W., Murray P.T., et al. Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46 (2005) 26-34
163. Tumlin J., Finckle K., Murray P., et al. Dopamine receptor 1 agonists in early acute tubular necrosis: A prospective, randomized, double blind, placebo-controlled trial of fenoldopam mesylate. J Am Soc Nephrol 14 (2003) PUB001
164. Renton M.C., and Snowden C.P. Dopexamine and its role in the protection of hepatosplanchnic and renal perfusion in high-risk surgical and critically ill patients. Br J Anaesth 94 (2005) 459-467
165. Lassnigg A., Donner E., Grubhofer G., et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11 (2000) 97-104
166. Mehta R., Pascual M., Soroko S., et al., Group ftPS. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288 (2002) 2547-2553
167. Ellison D.H., Velazquez H., and Wright F.S. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83 (1989) 113-126
168. Fisher A.R., Jones P., Barlow P., et al. The influence of mannitol on renal function during and after open-heart surgery. Perfusion 13 (1998) 181-186
169. Nishimura O., Tokutsu S., Sakurai T., et al. Effects of hypertonic mannitol on renal function in open heart surgery. Jpn Heart J 24 (1983) 245-257
170. Szabo T., DeSimone N., Moaref K., et al. The association between mannitol dose and postoperative acute renal injury in aortocoronary bypass surgical patients. Anesth Analg 102 (2006) SCA59
171. Mentzer Jr. R.M., Oz M.C., Sladen R.N., et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol 49 (2007) 716-726
172. Teerlink J.R., and Massie B.M. Nesiritide and worsening of renal function: The emperor's new clothes?. Circulation 111 (2005) 1459-1461
173. Brenner R.M., and Chertow G.M. The rise and fall of atrial natriuretic peptide for acute renal failure. Curr Opin Nephrol Hypertens 6 (1997) 474-476
174. Meyer M., Pfarr E., Schirmer G., et al. Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 21 (1999) 85-100
175. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
176. Van den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcome?. Ann Intern Med 146 (2007) 307-308
177. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 146 (2007) 233-243
178. Hoffmann U., Fischereder M., Kruger B., et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
179. Burns K.E., Chu M.W., Novick R.J., et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: A randomized controlled trial. JAMA 294 (2005) 342-350
180. Ristikankare A., Kuitunen T., Kuitunen A., et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 97 (2006) 611-616
181. Haase M., Haase-Fielitz A., Bagshaw S.M., et al. Phase II, randomized,
182. El-Hamamsy I., Stevens L.M., Carrier M., et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 133 (2007) 7-12
183. Kulka P.J., Tryba M., and Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit Care Med 24 (1996) 947-952
184. Kaya K., Oguz M., Akar A.R., et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: A prospective randomized clinical trial. Eur J Cardiothorac Surg 31 (2007) 290-297
185. Wijeysundera D.N., Beattie W.S., Rao V., et al. Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis. J Am Coll Cardiol 41 (2003) 1496-1505
186. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
187. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
188. Wijeysundera D.N., Naik J.S., and Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med 114 (2003) 742-752
189. Abe K., Fujino Y., and Sakakibara T. The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery. Eur J Clin Pharmacol 45 (1993) 217-220
190. Morgera S., Woydt R., Kern H., et al. Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 30 (2002) 107-112
191. Chatterjee P.K. Pleiotropic renal actions of erythropoietin. Lancet 365 (2005) 1890-1892
192. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55 (1999) 2423-2432
193. Hladunewich M.A., Corrigan G., Derby G.C., et al. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF. Kidney Int 64 (2003) 593-602
194. Zhou X., Ono H., Ono Y., et al. Renoprotective effects of omapatrilat are mediated partially by bradykinin. Am J Nephrol 23 (2003) 214-221
195. Kostis J.B., Packer M., Black H.R., et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 17 (2004) 103-111
196. Kim Y.K., Yoo J.H., Woo J.S., et al. Effect of pentoxifylline on ischemic acute renal failure in rabbits. Ren Fail 23 (2001) 757-772
197. Kim Y.K., Choi T.R., Kwon C.H., et al. Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail 25 (2003) 909-922
198. Boldt J., Brosch C., Piper S.N., et al. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29 (2001) 952-958
199. Loef B.G., Henning R.H., Epema A.H., et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 93 (2004) 793-798
200. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
201. Lee A., Cooper M.C., Craig J.C., et al. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev (2004) CD002765
202. Ott E., Nussmeier N.A., Duke P.C., et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 125 (2003) 1481-1492
203. Nussmeier N.A., Whelton A.A., Brown M.T., et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352 (2005) 1081-1091
204. Kramer B.K., Preuner J., Ebenburger A., et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 17 (2002) 910-915
205. Wang A., Holcslaw T., Bashore T.M., et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57 (2000) 1675-1680
206. Stafford-Smith M., Swaminathan M., McCreath B.J., et al. Morbidity-related serum creatinine patterns after coronary bypass surgery. Anesth Analg 92 (2001) SCA123
207. Ten Clay S., Phillips-Bute B., Glower D., et al. Aortic valve replacement and acute kidney injury: Minimally invasive parasternotomy versus median sternotomy. Anesth Analg 106 (2008) SCA124
208. Swaminathan M., Knauth K., Phillips-Bute B., et al. Acute renal dysfunction after cardiac transplant surgery: A comparison with other forms of cardiac surgery. Anesth Analg 94 (2002) SCA102
209. Lemmer Jr. J.H., Stanford W., Bonney S.L., et al. Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function. Ann Thorac Surg 59 (1995) 132-136